Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.

The disialoganglioside GD2 is expressed on a wide spectrum of human tumor types, including neuroblastomas and melanomas. Upon binding of 3F8, a murine monoclonal antibody (MAb) specific for GD2, neuroblastomas and some melanomas are sensitive to killing by human complement, whereas some melanomas ar...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cheung, N K, Walter, E I, Smith-Mensah, W H, Ratnoff, W D, Tykocinski, M L, Medof, M E
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1988
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC329640/
https://ncbi.nlm.nih.gov/pubmed/2450893
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia